Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Short-term Investments (2021 - 2025)

Zymeworks' Short-term Investments history spans 5 years, with the latest figure at $187.6 million for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 17.52% to $187.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $187.6 million, a 17.52% increase, with the full-year FY2025 number at $187.6 million, up 17.52% from a year prior.
  • Short-term Investments hit $187.6 million in Q4 2025 for Zymeworks, roughly flat from $187.1 million in the prior quarter.
  • Over the last five years, Short-term Investments for ZYME hit a ceiling of $259.2 million in Q2 2024 and a floor of $50.7 million in Q4 2021.
  • Historically, Short-term Investments has averaged $170.5 million across 5 years, with a median of $187.1 million in 2025.
  • Biggest five-year swings in Short-term Investments: soared 186.59% in 2023 and later decreased 29.34% in 2025.
  • Tracing ZYME's Short-term Investments over 5 years: stood at $50.7 million in 2021, then skyrocketed by 79.97% to $91.3 million in 2022, then skyrocketed by 137.37% to $216.8 million in 2023, then fell by 26.34% to $159.7 million in 2024, then grew by 17.52% to $187.6 million in 2025.
  • Business Quant data shows Short-term Investments for ZYME at $187.6 million in Q4 2025, $187.1 million in Q3 2025, and $183.1 million in Q2 2025.